Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
暂无分享,去创建一个
G. Wesolowski | G. Rodan | M. Rogers | J. Fisher | J. Halasy | S. P. Luckman | D. Hughes | P. Masarachia | A. Reszka | R. Russell